A fluorescent assay suitable for inhibitor screening and vanin tissue quantification

Area of Science:

• Biochemistry
• Enzymology
• Assay Development

Background:

• Vanin-1 is a pantetheinase enzyme crucial for pantothenic acid (vitamin B5) metabolism.
• Understanding vanin-1 activity is important for potential therapeutic interventions.
• Existing methods for measuring vanin-1 activity may lack sensitivity or throughput.

Purpose of the Study:

• To develop and validate a novel, highly sensitive fluorescent assay for quantifying vanin-1 pantothenase activity.
• To characterize recombinant human vanin-1 and its activity in various biological samples.
• To identify potential inhibitors of vanin-1 through high-throughput screening.

Main Methods:

• Development of a fluorescent assay using a novel fluorescently labeled pantothenate derivative.
• Characterization of purified recombinant human vanin-1 (extracellular domain).
• Quantification of vanin-1 activity in cell lines and tissue lysates (lung, liver, kidney).
• High-throughput screening of a compound library using the developed assay.
• Confirmation of enzymatic activity using liquid chromatography-mass spectrometry (LC-MS).

Main Results:

• The fluorescent assay demonstrated high sensitivity and reliability, suitable for 384-well microplate format (Z factor = 0.75).
• Vanin-1 activity was quantified in tissues, with highest activity observed in the kidney.
• Purified recombinant vanin-1 exhibited significant activity (apparent K(m) = 28 microM).
• Preliminary screening identified novel chemical scaffolds as potential vanin-1 inhibitors.

Conclusions:

• The developed fluorescent assay is a powerful tool for studying vanin-1 activity in biological systems.
• This assay facilitates target validation and drug lead discovery for vanin-1 related research.
• The findings support vanin-1 as a potential therapeutic target and highlight the utility of the new assay in drug development.